Table 3. Effects of treatment regimens on platelet‐derived microparticles.
| Baseline | Week 24 | Week 63 | |
|---|---|---|---|
| Total (n = 28) | 14.2 ± 7.6 | 9.4 ± 3.2* | 10.1 ± 3.8* |
| Val group (n = 14) | 15.5 ± 9.1 | 9.6 ± 3.8* | 10.9 ± 3.9* |
| Tel group (n = 14) | 12.9 ± 5.8 | 9.2 ± 2.7* | 9.3 ± 3.7* |
Data are expressed as the mean ± SD (U/mL). Tel, telmisartan; Val, valsartan; ACR, albumin/creatinine excretion ratio; PDMP, platelet‐derived microparticles. *P < 0.05 vs baseline.